Webinar | Age-Appropriate Formulation Development for Pediatric Trials: Challenges and Considerations
Date: Wednesdaday, January 29, 2020
Time: 11am EST (NA) / 4pm GMT (UK) / 5pm CET (EU-Central)
Duration: 1 hour
In 2018, the US Food and Drug Administration (FDA) released updated guidelines on Drug Development¹. That same year, the European Medicines Agency (EMA) also took the initiative to implement additional regulations supporting drug development in Europe². Since the release of these guidelines, overlooking factors such as acceptability, excipient considerations and caregiver instructions are no longer an option. In this complimentary webinar, experts will discuss the recent advances, challenges and considerations in drug development. Real-life examples presented by the experts will illustrate the impact of age-appropriate dose forms for pediatrics and highlight insights into the caregiver perspectives. Register for the webinar to learn about a case study on real-world medications and acceptability assessment. The experts will walk through solutions that address the challenges in pediatric drug development and have the potential to improve patient outcomes.
Key takeaways from this webinar include:
- Developing age-appropriate dose forms
- Factors in excipient decision-making
- Insights from a caregiver’s viewpoint
- Technologies for creating ideal dose forms
Take part in this webinar to learn more about new technologies for developing and delivering optimal dosage forms that address adherence and acceptability in pediatric populations.
Director of Scientific Services, Formulation Services
Rachel Meyers, PharmD, BCPS, BCPPS, FPPA
Clinical Associate Professor, Ernest Mario School of Pharmacy, Rutgers University
& Pediatric Clinical Pharmacist, Saint Barnabas Medical Center